Precision medicine could “revolutionize” the diagnoses and treatment of patients, 2bPrecise Chief Medical Officer Joel Diamond writes in a recent article on Medical Economics.
The momentum behind precision medicine has “countless physician groups” working to develop the best possible implementation of genetics in their practices, Diamond writes.
“The science of genomics has advanced at a rapid pace, and new discoveries about how these insights impact clinical decision-making are circulated almost weekly,” he writes. “Consumer demand is rising, thanks to regulatory approval for direct-to-consumer genetic testing and resulting media coverage.”
To read the full article, click here.
